Cord Blood Stem Cell TransplantationGraft SurvivalGraft vs Host Disease
Dr. George B. Selby, MD
NPI1679542963
- Medicare services, 2021
- 278
- Part D claims, 2021
- 74
- Publications
- 22
- Clinical trials
- 11
- MIPS score, 2024
- 77
- Practice address
- 1200 Childrens Ave, Oklahoma City, OK 73104
- Practice phone
- Call (405) 271-5100
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Oklahoma Children's Hospital
Oklahoma City, Oklahoma
Find Dr. Selby's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. George B. Selby is a hematologist and oncologist in Oklahoma City, Oklahoma
Dr. Selby practices at Oklahoma Children's Hospital in Oklahoma City, Oklahoma.
Dr. Selby's NPI, 1679542963, was assigned on March 17, 2006. Dr. Selby graduated from University of Oklahoma College of Medicine in 1980. Dr. Selby holds Oklahoma license 13143.
NPI and contact details
- NPI
- 1679542963NPI Registry (opens in a new tab)
- NPI enumeration date
- March 17, 2006
- NPI status
- Active
- Practice phone
- (405) 271-5100
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 72
- Medical school graduation
- 1980
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. George B. Selby practices at Oklahoma Children's Hospital in Oklahoma City, Oklahoma
Dr. Selby's primary practice is Oklahoma Children's Hospital, at 1200 Childrens Ave, Oklahoma City, OK 73104 in Oklahoma County. The practice phone is (405) 271-5100.
- Oklahoma Children's Hospital1200 Childrens Ave, Oklahoma City, OK 73104 · Oklahoma CountyPhone(405) 271-5100
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. George B. Selby is affiliated with 3 sites of care and 2 medical groups
Dr. Selby's primary practice is Oklahoma Children's Hospital in Oklahoma City, Oklahoma. The medical group on file is OU Health. Dmand AI also links Dr. Selby to 2 more group practices and clinics and 1 medical group, each named with a free account.
Oklahoma Children's HospitalPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. George B. Selby's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Selby practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Oklahoma Children's Hospital | Available with a free account |
| +2 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Selby practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. George B. Selby is one of 134 hematologists and oncologists in Oklahoma
Hematology and oncology is Dr. Selby's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Selby is licensed in Oklahoma.
Specialties and state licenses
- Hematology and oncology, OklahomaPrimary
Hematologists and oncologists near Dr. Selby
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. George B. Selby billed Medicare for 278 services in 2021
CMS data shows 278 Medicare services from Dr. Selby across 6 procedure codes in 2021. Medicare paid $20,817 for them.
Medicare services, 2021278
Paid by Medicare$20,817
Procedure codes6
Dr. Selby's Medicare services by type, 2020 to 2021
- 2020
- 2021
- Office and hospital visits
- 2020: 1342021: 278107%
- Other services
- 2020: 532021: 0100%
Where Dr. Selby's Medicare services took place, 2021
- In an office8832%
- In a facility19068%
Dr. Selby compared with the Oklahoma median for hematologists and oncologists, 2021
- Dr. Selby
- Oklahoma median
- Medicare services
- 278vs 1,21877% below
- Part D claims
- 74vs 82791% below
Medians across 124 hematologists and oncologists in Oklahoma with Dmand AI profiles that report each measure.
Dr. Selby's most billed Medicare procedure codes, 2021
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Selby?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Selby and other hematologists and oncologists in Oklahoma.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. George B. Selby's patients have a median age of 68
Across all payers, Dmand AI patient panel data puts Dr. Selby's median patient age at 68, with 0% women.
Dr. Selby's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women0%
- Men100%
Source: Dmand AI Patient Panel Data
Dr. George B. Selby wrote 74 Medicare Part D claims in 2021
In 2021, Dr. Selby wrote 74 Medicare Part D claims. They cover 4 drugs, with $210,340 in total drug cost. In 2020, CMS named 180 claims across 13 drugs.
Part D claims, 202174
Drugs named by CMS4
Total drug cost$210,340
Dr. Selby's most prescribed drugs by claims, 2021
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2020 to 2021
- 2020
- 2021
- Claims for drugs CMS names
- 2020: 1802021: 7459%
Drugs named by CMS: 4 in 2021, 13 in 2020.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
Dr. George B. Selby scored 77 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Selby for performance year 2024, reported as part of a group.
Dr. Selby's MIPS scores, performance year 2024
- 77of 100Final score
- 53.7of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 70of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Selby by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. George B. Selby has 22 publications on record
Dmand AI links 22 papers to Dr. Selby, published from 2014 to 2022. 2014 was the busiest year, with 7. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation, Homologous and Bone Marrow Transplantation. Dr. Selby has published most often in Biol Blood Marrow Transplant. Dr. Selby's most frequent co-authors are Mohamad Ali Cherry, MD, Luke Paul Akard, MD and Dennis L. Confer, MD.
Papers22
Years published2014 to 2022
Dr. Selby's papers by year, 2014 to 2022
Topics Dr. Selby writes about most
- Hematopoietic Stem Cell Transplantation
- Transplantation, Homologous
- Bone Marrow Transplantation
- Cryopreservation
- Graft vs Host Disease
- Hematologic Neoplasms
- Immunosuppressive Agents
- Transplantation, Autologous
Dr. Selby's most frequent co-authors
- Mohamad Ali Cherry, MD7 shared papers
- Luke Paul Akard, MD3 shared papers
- Dennis L. Confer, MD3 shared papers
Recent publications by Dr. Selby
Bone Marrow Transplant
Cell- and Tissue-Based TherapyFeasibility StudiesImmunotherapy, Adoptive
See who Dr. Selby researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Selby works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. George B. Selby has worked on 11 clinical trials
Dmand AI links Dr. Selby to 11 clinical trials, 5 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Anemia, Aplastic. National Cancer Institute (NCI) sponsors the most, 4. Open Payments lists research payments to Dr. Selby that name 1 trial.
Clinical trials with Dr. Selby by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 2Phase 2: 2 trials
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Selby's trials
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid
- Anemia, Aplastic
- Anemia, Sickle Cell
- Burkitt Lymphoma
Investigators on the most trials with Dr. Selby
- Terrence P. Cescon, MD3 shared trials
- David F. Claxton, MD3 shared trials
- Robert Michael Eisner, DO3 shared trials
Recent clinical trials with Dr. Selby
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (opens in a new tab)
Active, not recruitingPhase 2
Leukemia, Myeloid, AcuteLeukemia, MyeloidGilteritinibMidostaurinCytarabine
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma (opens in a new tab)
Active, not recruitingPhase 3
Hodgkin DiseaseLymphomaBrentuximab VedotinNivolumabDacarbazine
Anemia, Sickle CellAnemia, Hemolytic, Congenital
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma (opens in a new tab)
Active, not recruitingPhase 2
Lymphoma, FollicularLymphoma, Non-HodgkinLenalidomideObinutuzumabUmbralisib
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (opens in a new tab)
Active, not recruitingPhase 3
IbrutinibCarmustineCyclophosphamide
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. George B. Selby received $1,590 in industry payments from 2016 to 2021
CMS Open Payments shows 32 general payments to Dr. Selby from 13 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 100% of the total. Jazz Pharmaceuticals Inc. paid the most, $451. It also lists 1 research payment totaling $2,500 in 2016, naming 1 clinical trial.
General payments to Dr. Selby by program year, 2016 to 2021
Companies that paid Dr. Selby the most, 2016 to 2021
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. George B. Selby graduated from University of Oklahoma College of Medicine
Dr. Selby graduated from University of Oklahoma College of Medicine in 1980.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. George B. Selby's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. George B. Selby
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. George B. Selby's NPI number?
Dr. George B. Selby's NPI number is 1679542963. It was assigned on March 17, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. George B. Selby?
Dr. George B. Selby is a hematologist and oncologist in Oklahoma City, Oklahoma. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. George B. Selby practice?
Dr. Selby practices at 1200 Childrens Ave, Oklahoma City, OK 73104. Dr. Selby's primary practice is Oklahoma Children's Hospital in Oklahoma City, Oklahoma. Dmand AI also links Dr. Selby to 2 group practices and clinics and 1 medical group.
What is Dr. George B. Selby's office phone number?
The practice phone on file for Dr. Selby is (405) 271-5100.
What is Dr. George B. Selby's medical license number?
Dr. Selby holds Oklahoma license 13143.
What medical group is Dr. George B. Selby part of?
Dr. Selby is linked to OU Health. Dmand AI links Dr. Selby to 1 more medical group.
Does Dr. George B. Selby accept Medicare?
Yes. CMS data shows Dr. Selby billed Medicare for 278 services in 2021.
What is Dr. George B. Selby's MIPS score?
Dr. Selby's MIPS final score for performance year 2024 is 77 out of 100, reported as part of a group.
What services does Dr. George B. Selby bill to Medicare?
In 2021, Dr. Selby's most billed Medicare services were hospital inpatient care (99232), hospital inpatient care (99233) and office visit, established patient (99214).
Where did Dr. George B. Selby go to medical school?
Dr. Selby graduated from University of Oklahoma College of Medicine in 1980.
Show 5 more questionsShow fewer questions
What drugs does Dr. George B. Selby prescribe most?
In 2021 Medicare Part D data, Dr. Selby's most prescribed drugs by claims were Acyclovir, Allopurinol and Jakafi.
Has Dr. George B. Selby received payments from drug or device companies?
CMS Open Payments shows $1,590 in general payments to Dr. Selby from 13 companies from 2016 to 2021. The largest total came from Jazz Pharmaceuticals Inc.
How long has Dr. George B. Selby been practicing?
Dr. Selby graduated from medical school in 1980, 46 years ago.
Does Dr. George B. Selby do research?
Dmand AI links 22 publications to Dr. Selby, published from 2014 to 2022. Dr. Selby has worked on 11 clinical trials.
Who does Dr. George B. Selby publish with?
Dr. Selby's most frequent co-authors are Mohamad Ali Cherry, MD (7 shared papers), Luke Paul Akard, MD (3 shared papers) and Dennis L. Confer, MD (3 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Oklahoma by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card